The aim of this study was to prepare a stable nanostructured lipid carrier ( with HeLa cells while the DTX-NLC was more cytotoxic than pure DTX at the same drug concentration. DTX-NLC could be taken up into the cells more than pure DTX, which could be attributed to the better solubility of DTX after loading into NLC.
Introduction
Drug delivery device is reported to enhance efficiency and reduce side effects of cytotoxic drugs. Various advanced nanostructures (including micelles, liposomes, solid lipid nanoparticles, nanostructured lipid carriers and polymeric nanoparticles)
have been developed. [1] The lipid nanoparticles (including solid lipid nanoparticles and nanostructured lipid carriers) are composed of lipids similar to physiological ones, which offer various advantages making them the ideal delivery vehicles.
Nanostructured Lipid Carrier (NLC) is the second generation of lipid nanoparticles.
Comparing with solid lipid nanoparticle (SLN), NLC is produced by controlled mixing of solid lipids with spatially incompatible liquid lipids, which results in special nanostructures with improved properties for drug loading and stable drug incorporation during storage. [2] Lipid nanoparticles have been proposed as alternative carriers to well-known liposomes and polymeric nanopartices in order to overcome some of common problems. The application of lipid nanoparticles is very wide including cancer treatment, transfection, liver targeting, imaging, targeting the central nervous and etc. [3] Daniela M.R. etc. prepared tretinoin loaded Chitosan-solid lipid nanoparticles (SLNs-chitosan-TRE) for skin delivery. They found that SLNs-chitosan-TRE had high encapsulation efficiency, high physical stability for one year, were not cytotoxic to keratinocytes and had high antibacterial activity against P. acnes and S.
aureus. [4] Recently the shape and microstructure of carriers have been identified as one of key factors that influence important biological processes, including biodistribution 4 and cellular uptake. [5] Many investigations have led to significant advances in understanding the impact of key NLC properties such as size, surface chemistry and shape on their performance. [6] [7] [8] For better understanding of lipid nanoparticles and their controlled release development, it is necessary to study the inner microstructure of this special lipid matrix. [9] In this study, small-angle neutron scattering and smallangle X-ray scattering were used to determine the microstructure of the lipid carrier Docetaxel is reported as an inhibitor of microtubule depolymerization and has broad antitumor activities against a variety of solid tumors, including breast, nonsmall cell lung cancer, ovarian and so on. [10] [11] [12] [13] However, its clinical efficiency is limited due to its poor solubility, low bioavailability and high toxicity. [14] Various drug carriers including hyaluronic acid-ceramide (HA-CE)-based self-assembled nanopartices [15] , liposomal nanoparticles [16] and solid lipid nanoparticles [17] were used to load DTX to broaden its clinical application. [18] [19] [20] [21] Some researchers have prepared docetaxel-loaded SLN with a galactosylated conjugated DOPE lipid to specifically target the asialo-glycoprotein receptor on hepatocellular carcinoma cells. [22] Li etc.
have prepared freeze-dried docetaxel NLCs, which had a spherical or ellipsoid shape, with 97.6% drug entrapment efficiency. They found that freeze-dried docetaxel NLCs showed high uptake in RES organs after intravenous administration, and the docetaxel concentration in the lungs was significantly higher with NLCs than following injection of docetaxel solution. [23] An improved cytotoxicity against A549 cells has also been obtained by encapsulating docetaxel in NLCs. The inhibition rate of docetaxel NLCs was 90.36%, while that of commercial Duopafei ® was only 42.74%, 5 indicating that docetaxel NLCs are more effective inhibitors of tumor growth. [24] In the present study, DLS, TEM, SANS, SAXS and XRD measurements were used for structure characterization including shape, size and inner microstructure of NLC, and DTX was used as API to study the effects of lipophilic drug on NLC. 
Materials and methods

Materials
Preparation of nanostructured lipid carrier
Blank NLC and DTX-NLC were prepared by HPH. In brief, aqueous and oil phase were prepared separately. Lipid mixtures (SA, MGE, MCT and OA) were maintained at 70 °C to prevent the recrystallization of lipids during the process, and then DTX was added to oil phase until it totally melted. The same temperature aqueous phase (F68, EL and ultra purified water) was added to the oil phase with intense stirring (10000 rmp for 1 min; Turrax T25, Fluko, Germany). The dispersion 6 was processed through a high-pressure homogenizer with five homogenization cycles at 600 bar. The nanodispersion was cooled overnight at room temperature.
Appropriate amounts of Trehalose (3%, w/v) were used to dilute the NLCs dispersion.
All the samples were frozen at -78 °C for 10h before being lyophilized for 36 h. The freeze-dried powders were rehydrated at phosphate buffer solution buffer (PBS, pH7.4) for later experiments.
Surface tension
The surface tension was measured by Wilhelmy small plate method on liquid measuring apparatus Dataphysics (DCAT21, Germany) at room temperature. The platinum plate was first cleaned and roasted in a red flame before each measurement.
The system was corrected by purified water, and The data was calibrated to the surface tension of purified water. All the samples were measured three times.
Dynamic light scattering
The mean particle size and polydispersity index (PDI) of blank NLC and DTXNLCs were measured three times by dynamic light scattering at 25 °C using Nano-ZS90 system (DLS, Malvern Instruments Ltd., UK) with a measurement angle of 90 °.
Entrapment efficiency and drug loading
Briefly, the desired amount of DTX-NLCs was rehydrated in PBS (pH 7.4) and was centrifuged for 15 min at 12,000 rpm at 4 °C to remove the unentrapped drug from samples. The upper aqueous phase from first step was placed into centrifuge tube and methanol was added to destroy the structure of NLCs. 
Transmission Electron Microscopy
The shape and morphologies of NLCs were determined by JEM-1400 electron microscope (JEOL, Tokyo, Japan). For TEM measurement, samples were prepared by placing a drop of fresh prepared DTX-NLC and Blank-NLC suspension onto a copper grid and air-dried, followed by negative staining with a drop of 1% aqueous solution of sodium phosphotungstic acid for contrast enhancement. Then the samples were dried in the air before TEM observation.
[25]
Small Angle Neutron Scattering (SANS)
SANS measurements were performed on the Yellow Submarine instrument at the BNC in Budapest (Hungary). [26] The overall q-range was from 0.03 to 1 nm 
Small Angle X-ray Scattering (SAXS)
The SAXS measurements were performed at a laboratory SAXS instrument 
Wide Angle X-ray powder diffraction (XRD)
Crystalline structure of DTX, unloaded blank NLCs and DTX-NLCs were investigated by D/MAX 2550 VB/PC X-ray diffractometer (Rigaku, Japan) using a Cu K α radiation source. Aqueous blank NLC and DTX-NLC were lyophilized before the XRD measurement. Diffractograms were recorded from the initial angle 2θ =10°
to the final angle 60°. The obtained data were collected with a step width of 0.02°
and a count time of 1s.
Cell culture
The human cervical cancer cell line HeLa was purchased from American Type 9 Culture Collection (Manassas, VA, USA). HeLa cells were seeded onto cell culture dishes containing DMEM and RPMI-1640 respectively supplemented with 10% fetal bovine serum, L-glutamine (5 mmol/L), non-essential amino acids (5 mmol/L), penicillin (100 U/ml), and streptomycin (100 U/ml) (Invitrogen, Carlsbad, CA, USA), at 37 °C in humidified 5% CO 2 atmosphere. 
In vitro cellular cytotoxicity assays
Results and discussion
Preparation of nanostructured lipid carrier
The composition of nanoparticle shells significantly affects the in vitro release of medicine and its performance in blood. [27] [28] It is important to choose suitable 10 surfactants for NLC preparations. In our study, the drug delivery system was stabilized with two non-ionic surfactants, Pluronic F68 and Cremophor EL.
Cremophor EL is FDA approved, and already clinically used for intravenous injection.
The long PEG tail of Pluronic F68 can also act as a steric stabilizer. Both of them are common for the preparations of SLN and NLC.
Surface tension was measured to determine the optimal ratio between F68 and EL and also their concentrations. Given the fact that the surface tension was changing in the first several hours after preparation, all experiments were performed 24 hours later. As reveled by Table 1 Tween-80 and Crempher are highly hydrophobic; hence they are formulated as delivery ingredients in current preclinical studies. However, such surfactants can cause significant hypersensitivity and toxicity issues, especially if multiple doses are used, [29] [30] [31] so F68 is more advantageous. In addition, it was found (see Table 1 ) that the surface tension was decreasing with higher surfactant concentration, but it did not change much when the ratio between F68 and EL were 1/1 and 1/2. It was reported that too much surfactants would result in drug burst release and NLC instability. [32] [33] From Table 1 , it can be seen that pure EL has lower surface tension than pure F68, especially at the concentration of 1mg/ml, which indicate that EL has better surface 11 activity than F68. So, the surface tension of F68/EL solution will decrease with the addition of EL to F68 solution. Therefore, the diminishing effect of F68/EL ratio on surface tension is more pronounced at higher mass concentration (10 mg/ml).
Consequently, the ratio between F68 and EL was fixed as 1/1, and the concentration of surfactants was 5 mg/ml for the reason that 1mg/ml surfactants may result in poor long-term stability of NLC. The liquid lipids were reported to promote the formation of small-particles as a result of the higher mobility of the matrix. [35] [36] OA and MCT mixed with solid lipids (SA and MGE) were used as core materials for the NLC due to their good solubilization of the poorly soluble drug. The ratios between them also influence strongly the mean particle size and polydispersity index of DTX-NLC. In addition to 12 being lipid core, SA and MGE provide emulsification and form more rigid surfactant films. [34] It is reported that the oil precipitates separately at high concentration during cooling process. The location of the separated oil phase depends on the nature of lipid components, the ratio between lipids and production conditions. [37] Finally, the ratio between solid/liquid lipid was fixed as 2/1. [18] MCT as a liquid lipid provides thermodynamic stability and high solubility for many drugs. [38] The particle size of This was because OA increased the mobility of the internal lipids and fluidity of the surfatant layer due to the low melting point of OA. [39] Also the particle diameters of The formulation composition was as follows: In 100 ml of ultra purified water, there were 596 mg SA, 1047 mg MGE, 593 mg MCT and 237 mg OA as oil phase.
Then, 250 mg F68, 250 mg EL, and 5 mg of DTX as drug were added.
Entrapment efficiency and drug loading
As shown in Table 3 , the mean particle size and PDI of both blank NLC and DTX-NLC increased a lot after 30 days of preparation, which indicated that some big 14 particles appeared. The enlarged lyophilised particle size may be explained by an increased hydrodynamic diameter of the NLCs due to coating of the particle surface with the saccharides through hydrogen bonding with lipids. [23] It is expected that the solid state of the lyophilisation will have a better chemical and physical stability than aqueous lipid dispersions. However, two additional transformations between the formulations might be the source of additional stability problems. The first transformation -from aqueous dispersion to powder -involves the freezing of the sample and the evaporation of water under vacuum. Freezing of the sample might cause stability problems due to the freezing out effect which results in changes of the osmolarity and the pH. The second transformation -resolubilization -involves, at least in its initial stages, situations which favor particle aggregation (low water and high particle content, high osmotic pressure). [40] In addition, the encapsulation efficiency values of DTX-NLC decreased from (60.5±5.0) % to (55.3±4.5) %, and drug loading values also reduced from (0.28±0.01) % to (0.18±0.02) %, which meant some drug had been released from NLC. It was reported that during cooling process after HPH, some drug may locate in the surface layer instead of the core of NLC, and it was likely that these DTX were lost in the following days. [41] The surfactants and lipids can form micelles, liposomes and other aggregates in aqueous solution. DTX can also be loaded into these aggregates. So, there is no obvious drug separation found in samples after rehydration. But it was likely that these DTX easily lost during the re-dispersion process. The decrease of DL% is shown in Table 3 . This phenomenon is similar with results reported by K.
Zheng etc. [42] Other factors such as freezing and drying could also lead to DTX losses. It must be noticed, the load amount of DTX in sample was greatly decreased from 1 day to 30 days, which has been described as the drug burst release by Müller etc. for a number of SLN and it also could not be avoided for NLC. [40, [43] [44] [45] To achieve prolonged release, special production conditions such as low surfactant content and low preparation temperature are recommended. [46] Moreover, the DL% and EE% of DTX-NLC were not as high as reported before. [20] [21] The main reason was the limited solubility of DTX in the chosen lipid mixture. DTX is water-insoluble. According to our experiments, the solubility of DTX in molten SA, MGE, MCT and OA were 5.2 mg/g, 17.7 mg/g, 7.9 mg/g and 18.9 mg/g, respectively. It is obvious that the solubility of DTX in these lipids was much higher compared to water. In a previous work, it was found that 1614 mg lipid mixture composed by SA, MGE, MCT and OA could dissolve 200mg CMT-3, which was a lipophilic drug too [47] . It was proved that these lipids can improve the solubility of water-insoluble drug. However, this improvement for DTX was still limited.
To assess system stability, zeta potential measurement was further performed. although the obvious change of particle size, entrapment efficiency and drug loading. Note: PDI means polydispersity index. Data were given as mean ± SD (n=3)
Transmission Electron Microscopy
TEM measurement was used to study the morphology of NLC (Fig. 2) . From   Fig. 2 , it can be seen that DTX-NLCs and blank-NLCs were spherical or elliptical in shape and were evenly distributed in the inner grid structures. [18, 23] The blank NLC and DTX-NLC had similar characters, which demonstrated that the entrapment of DTX would not significantly influence the shape of the NLC. DLS measurement of non-spherical particles will have deviation due to the assumption of the theoretical model of DLS is to test monodisperse and spherical particles. Non-spherical particles cause broadening of the particle size distribution as compared to the equivalent volume distribution. Moreover, the median and mean diameter may be shifted, often to a lager size. According to TEM images, the particle size of blank-NLC ranged from 95 nm to 180 nm, and the particle size of DTX-NLC ranged from 120 nm to 200 nm.
These results are in agreement with the DLS results, where the particle size of blank-NLC and DTX-NLC were 136.4±3.5 nm and 145.6±2.5 nm, respectively. 
Small Angle Neutron Scattering (SANS)
SANS was used to study the effects of DTX on structure changes of NLC ( Fig   3A) . 
Small Angle X-Ray Scattering (SAXS)
The three-dimensional structures of freeze-dried DTX-NLC and blank NLC were studied by SAXS. There were two peaks (Fig. 3B, blank NLC arranged into cubic 3-dimensional structures. [48] Addition of DTX into NLC did not change the cubic structure of the blank NLC. The regular crystalline-like structure is expected to be good for sustained release profile. The solid matrix of NLC contains tiny liquid nanocompartments of oil. In these oil compartments the drug solubility is higher, thus increasing the total drug loading capacity. The nanocompartments are surrounded by solid lipid matrix, allowing prolonged drug release. [44] Also NLC is composed of solid lipid and liquid lipid, and such complex structure is beneficial for sustained drug release. [45] The low q part of SAXS data has been analyzed by dimensional analysis similar to SANS data obtained for NLC samples. For blank NLC, the slope remained constant 
In vitro cellular cytotoxicity assays (MTT)
In order to know the activity of DTX-NLC on cells, the cellular cytotoxicity was also evaluated by MTT assay. (Fig. 5) . Also DTX-NLC showed higher cytotoxicity against HeLa cells at lower concentration than pure DTX at higher concentration. For example, the viability of HeLa cells treated with 12 nM DTX -NLC for 24 h was less than the one treated with 24 nM pure DTX for 24 h. However, at the concentration of 120 nM, both DTX and DTX-NLC exhibited significant but equivalent inhibition effects on HeLa cells. That is to say NLC slightly increased the treatment efficiency of relatively lower concentration of DTX, which might be due to the better solubility of DTX after being loaded into NLC. The more effective treatment of NLC formulations could be also attributed to the targeting ability of nanosized NLC, which were taken up into the cells more effectively. [49] In previous work, we performed the cell uptake studies in order to observe the intracellular distribution of NLC. [47] Those studies showed that NLC can rapidly enter into the 21 cell's cytoplasm, which can explain the slightly higher cytotoxicity of DTX/NLC compared to DTX alone. Small particles ranging between 120 and 200 nm only rarely undergo blood clearance by the cells of the reticulo-endothelial system (RES), therefore liver and spleen filtration is avoided, which means NLC has passive drug targeting property. [49] In addition, blank NLC showed <3% cytotoxicity. 
Conclusion
In this study, stable nanostructured lipid carrier with mean particle size less than 200 nm was successfully prepared by high-pressure homogenization. Docetaxel was used as active pharmaceutical ingredient to study the NLC effects on its drug effect.
The mean particle size of DTX-NLC was in the range of about 120 nm to maximum 
